Status:
COMPLETED
Systemic Mechanisms in Allergic Rhinitis: Assessment of Metabolomic Outcomes.
Lead Sponsor:
Queen's University
Conditions:
Allergic Rhinitis
Eligibility:
All Genders
18-55 years
Brief Summary
This clinical study will use the Environmental Exposure Unit (EEU) to generate allergic rhinitis symptoms in participants under controlled conditions, to collect well-characterized biological samples ...
Eligibility Criteria
Inclusion
- Participant is a healthy, ambulatory male or female volunteer 18 to 55 years of age.
- Participant has a history of Seasonal Allergic Rhinitis due to ragweed for the last two consecutive ragweed seasons.
- Participant has a positive response (wheal diameter greater than or equal to 3 mm larger than diluent control) to a skin prick test to short ragweed allergen at screening or within 12 months of screening visit.
Exclusion
- Participant is a female that is pregnant, lactating or actively trying to become pregnant.
- smokers
- Participant is unable to comply with the washout periods for prohibited medications.
- Participant is currently receiving allergen specific immunotherapy injections.
Key Trial Info
Start Date :
August 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2014
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT02230475
Start Date
August 1 2014
End Date
September 1 2014
Last Update
April 21 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kingston General Hospital
Kingston, Ontario, Canada, K7L2V6